Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Pozycja w akcjach #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Cena akcji
$0.0202
Ostatnia synchronizacja: 2024-11-19
Kapitalizacja rynkowa
$44.67K
Zmiana (1 dzień)
-0.49%
Zmiana (1 rok)
0.00%
Kraj
IL
Handel Notable Labs, Ltd. (NTBL)

Kategoria

Historia ceny akcji dla Notable Labs, Ltd. (NTBL)
Najwyższa cena zamknięcia: $0.07 dnia 2024-11-01

Najniższa cena zamknięcia: $220.88 dnia 2014-10-01
Historia cen akcji firmy Notable Labs, Ltd. od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 -97.63%
2023 -35.28%
2022 -94.02%
2021 21.62%
2020 45.36%
2019 14.25%
2018 -84.70%
2017 40.20%
2016 -5.03%
2015 -14.31%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$524.11 32.38%
US
$869.90 34.53%
NL
$746.26 9.13%
CH
$1.08K -6.68%
KR
$260.48 16.92%
BE